QSAR Modeling of Carcinogenic Risk Using Discriminant Analysis and Topological Molecular Descriptors

E-ISSN： 1875-6220|2|2|55-67

ISSN： 1570-1638

Source： Current Drug Discovery Technologies, Vol.2, Iss.2, 2005-06, pp. : 55-67

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

QSAR Modeling of Anti-HIV Activities of Alkenyldiarylmethanes Using Topological and Physicochemical Descriptors

By Leonard J. Roy Kunal

Drug Design and Discovery, Vol. 18, Iss. 4, 2003-01 ,pp. : 165-180

Taylor & Francis Ltd

Access to resources Recommend Favorite

QSAR of Chalcones Utilizing Theoretical Molecular Descriptors

Current Computer - Aided Drug Design, Vol. 11, Iss. 2, 2015-09 ,pp. : 184-193

Bentham Science Publishers

Access to resources Recommend Favorite

Application of Topological Descriptors in QSAR and Drug Design: History and New Trends

Current Drug Targets - Infectious Disorders, Vol. 2, Iss. 1, 2002-03 ,pp. : 93-102

Bentham Science Publishers

Access to resources Recommend Favorite

Receptor-Based Pharmacophore and Pharmacophore Key Descriptors for Virtual Screening and QSAR Modeling

Current Computer - Aided Drug Design, Vol. 7, Iss. 3, 2011-09 ,pp. : 181-189

Bentham Science Publishers

Access to resources Recommend Favorite

A QSAR Study of HIV Protease Inhibitors Using Theoretical Descriptors

Current Computer - Aided Drug Design, Vol. 6, Iss. 4, 2010-12 ,pp. : 269-282

Bentham Science Publishers

Access to resources Recommend Favorite